Biosim AI
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Biosim AI was a College Park, Maryland startup founded in 2020 by Garegin Papoian, a chemistry professor at the University of Maryland. It built an AI platform to enable and accelerate drug discovery at quantum accuracy, using advanced computational methods and molecular simulation to cut small-molecule drug discovery timelines from years to months.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Garegin Papoian founds Biosim AI in College Park, Maryland to commercialize his computational chemistry research for drug discovery.
- Acquisition
In January 2024 Biosim AI merges with Deep Origin, joining forces on physics-plus-AI drug discovery.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.